Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 3 1

Status

Unknown 3Withdrawn 2Recruiting 2Completed 2Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Stomach Neoplasms 1Postgastrectomy Syndromes 1Pancreatic Neoplasms 1

Interventions

Cyclophosphamide 129Cisplatin 119Radiotherapy 115pembrolizumab 111Carboplatin 97Paclitaxel 96Gemcitabine 96Magnetic Resonance Spectroscopy 80Nivolumab 76Bevacizumab 76Fluorouracil 74Dexamethasone 73Radiosurgery 66Docetaxel 59Rituximab 58Leucovorin 57Oxaliplatin 55Capecitabine 55Biopsy 53Doxorubicin 52fludarabine 51Drug Therapy 45durvalumab 44Cytarabine 44Etoposide 42fludarabine phosphate 40Pemetrexed 40Radiation 39atezolizumab 36Surveys and Questionnaires 36

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Withdrawn × Gastroenterostomy × Clear all
NCT01569282 2019-03-22

Double Bypass Versus Stent-treatment in Irresectable Pancreatic Cancer

Göteborg University

Phase NA Withdrawn
Gastrointestinal

Pancreatic Neoplasms

NCT00622804 2009-08-03

Comparison Study for Bile Reflux and Gastric Stasis in Patients After Distal Gastrectomy

The Catholic University of Korea

Phase 3 Withdrawn
90 enrolled
Gastrointestinal

Postgastrectomy Syndromes, Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡